Why PM2.5 is the most dangerous of the three pollutants
PM2.5 (fine particles smaller than 2.5 micrometers) is the most harmful because it is small enough to bypass the body's defenses, travel deep into the lungs, and even enter the bloodstream. A large meta-analysis of studies since 2014 found that for every 10 µg/m³ increase in PM2.5, the risk of developing any type of cancer rises by 8.5%, and the risk of dying from cancer increases by 2.5% [1]. This effect was strongest for lung cancer, especially in Europe, where the relative risk was 2.15 (meaning more than double the risk) [1].
PM2.5 also affects the brain. A pooled analysis of 21 studies found that higher PM2.5 exposure was linked to a 49% increase in the odds of cognitive decline (OR 1.49) [3]. This means that people living in areas with higher PM2.5 levels are significantly more likely to experience memory loss, reduced thinking speed, or other cognitive problems.
Furthermore, PM2.5 is linked to obesity. A systematic review of 12 studies found that people exposed to higher PM2.5 levels had 18% higher odds of being obese (OR 1.18) [2]. The proposed mechanisms include inflammation and hormonal disruption caused by the particles entering the body.
PM10 targets the lungs, while ozone hits the heart and metabolism
PM10 (particles up to 10 micrometers) is coarser and tends to get trapped in the upper airways, causing irritation and inflammation. It is still dangerous, but its effects are generally weaker than PM2.5. The same meta-analysis found that PM10 exposure increased lung cancer risk, but with a lower relative risk of 1.26 (26% higher risk) compared to PM2.5's 2.15 [1]. PM10 was also linked to a 30% higher odds of cognitive decline (OR 1.30), though this result was borderline in statistical significance [3].
Ground-level ozone (O3) works differently. It is a highly reactive gas that does not penetrate as deeply as PM2.5, but it strongly affects the cardiovascular system. A study of 373 elderly people in Beijing found that short-term increases in ozone were linked to rises in diastolic blood pressure, blood sugar (HbA1c), and blood fats (triglycerides) [5]. For example, a typical increase in ozone (63 µg/m³ over 2 days) was associated with a 32% increase in triglycerides in people with high stress [5].
Ozone is also linked to obesity, but the effect is much smaller than for PM2.5. The same review found that ozone exposure raised obesity odds by only 1% (OR 1.01), which is statistically significant but practically negligible [2]. This suggests ozone's main health threat is through cardiovascular and metabolic disruption, not weight gain.
Your stress level and where you live can change how much these pollutants hurt you
The harm from air pollution is not the same for everyone. Psychosocial stress dramatically amplifies the effects of both PM2.5 and ozone on cardiovascular health. In the Beijing study, people with high perceived stress who were exposed to PM2.5 saw their triglycerides increase by 21%, while those with low stress actually saw a 20% decrease under the same pollution levels [5]. For ozone, the effect was even more striking: high-stress individuals had a 32% rise in triglycerides, compared to only 8% in low-stress individuals [5]. This means that stress makes the body more vulnerable to pollution's toxic effects.
Where you live also matters. A study covering all of Southeast Asia estimated that air pollution (mostly PM2.5 and ozone) causes about 900,000 premature deaths each year in the region, with 77% due to local emissions and 23% from pollution drifting across borders [4]. In Romania, the risk of dying from any cause due to PM10 varied significantly between regions, from a 1.7% increase in Bucharest to a 2.5% increase in western areas [6]. These differences are driven by local sources like industry, traffic, and agriculture, as well as weather patterns that trap or disperse pollution.
About These Sources
This answer is built on 6 peer-reviewed studies — published from 2021 to 2024, 4 from 2024 or later, 4 in Q1 journals, collectively cited 195 times — selected as the most relevant from 8 studies that passed quality screening, drawn from 52 papers retrieved from a database of over 500 million.
Sources used in this answer
A meta-analysis of the carcinogenic effects of particulate matter and polycyclic aromatic hydrocarbons
A meta-analysis of studies since 2014 found that PM2.5 exposure (per 10 µg/m³) increased overall cancer incidence by 8.5% and cancer mortality by 2.5%, with the highest lung cancer risk in Europe (RR 2.15).
Effect of environmental pollutants particulate matter PM2.5, PM10, nitrogen dioxide (NO2) and ozone (O3) on obesity
A systematic review of 12 studies found that PM2.5 (OR 1.18), PM10 (OR 1.11), and ozone (OR 1.01) were all significantly associated with higher odds of obesity, with PM2.5 showing the strongest effect.
Effect of air pollutants particulate matter (PM2.5, PM10), sulfur dioxide (SO2) and ozone (O3) on cognitive health
A pooled analysis of 21 studies found that PM2.5 exposure was linked to a 49% increase in the odds of cognitive decline (OR 1.49), with PM10 (OR 1.30) and SO2 also showing significant effects.
Source emission contributions to particulate matter and ozone, and their health impacts in Southeast Asia
Air quality modeling for Southeast Asia estimated that PM2.5 and ozone cause ~900,000 premature deaths annually, with 77% from local emissions (dominated by industry and residential burning) and 23% from transboundary pollution.
Does psychosocial stress modify the association of fine particulate matter and ozone with cardiovascular health indicators?
In a cross-sectional study of 373 elderly in Beijing, short-term PM2.5 and ozone exposure were linked to increased blood pressure and blood fats, with effects amplified 2-4 times in people with high psychosocial stress.
The human health risk assessment of particulate air pollution (PM2.5 and PM10) in Romania
In Romania (2009-2018), PM10 exposure was linked to a 2.0% average increase in all-cause mortality risk, while PM2.5 was more strongly tied to cardiopulmonary (RR 1.26) and lung cancer (RR 1.42) morbidity.